ArticleScientific reports2026
Protective effects of skin-derived precursor cell exosomes against UVB-induced skin photodamage.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Skin photodamage affects appearance and increases cancer risk, yet existing treatments are inadequate. Our prior data indicate that skin-derived precursors (SKPs) protect against photodamage via exosome-mediated signaling, though the mechanism is unclear. Exosomes are stable stem cell regulators, but SKPs-derived exosomes (SKPs-Exo) are underexplored in photodamage. To assess SKPs-Exo's therapeutic potential and mechanism in UVB-induced skin damage using mouse and 3D skin models. SKPs-Exo were isolated via ultracentrifugation and characterized by TEM, NTA, and WB. UVB-irradiated mice and 3D skin models received varying SKPs-Exo doses. We evaluated skin damage, apoptosis (TUNEL), oxidative stress (ROS, MDA, GSH, SOD), inflammation (IL-1β, IL-6, TNF-α), and Nrf2, HO-1, BACH1, and NF-κB expression. SKPs-Exo (30-200 nm) expressed CD9, CD63, and TSG101. UVB-induced damage, apoptosis, oxidative stress, and inflammation were dose-dependently reduced by SKPs-Exo, which restored antioxidants, suppressed inflammation, and modulated Nrf2/HO-1 and BACH1/NF-κB pathways (P < 0.05 or P < 0.01). SKPs-Exo alleviate UVB-induced skin damage by reducing apoptosis, oxidative stress and inflammation, likely via activating the Nrf2/HO-1 pathway and suppressing the BACH1/NF-κB pathway, providing a potential therapeutic direction for skin photodamage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.